Klykov Sergey Evgenyevich

Klykov Sergey Evgenyevich

Education

Sergey Klykov graduated from the Kuban State technology university majoring in "Economy and management in HSC".

In 2005 defended the master's thesis.

Career

In 2005 worked as the CEO of JSC Maslozhirkombinat Krasnodarsky. Held this post till 2006.

Then till 2014 headed Starched Plant Gulkevichsky LLC where its command made break on increase in a market share and capitalization of the enterprise.

In April, 2016 headed the Unitile group integrating the plants "Shakhty Ceramics", "Voronezh Ceramics", "Markinsky Brick-works", "Vladimirovsky Pit of High-melting Clays", Parallel Trading house, 18 branches on all Russia. In two years Klykov's team showed significant growth of financial results and brought to the market a number of new products and formats, in particular, in a bonus segment.

In November, 2018 it is appointed the CEO of JSC Pharm-center (enters c Marathon Group) — management company "Joint-stock Kurgan company medical of medicines and products "Synthesis" and Biolump Ltd.

Expansion of production and output to the market of new medicines will become a priority task of the head of the plants — the chairman of the board of Marathon Group Sergey Zakharov commented on appointment. — Sergey has a wide experience of successful management of production assets. I think that its examination will allow to bring Synthesis and Bioky to new level. We are glad to welcome Sergey in a command and we wish him success.

"Synthesis" — one of the largest pharmaceutical enterprises of Russia. We are faced by interesting and ambitious challenges of disclosure of its potential: bring new developments to the market, implement the strategy of long-term development in all product segments, expand sales channels", – Sergey Klykov tells.

For February, 2019 is also the CEO "Joint-stock Kurgan company medical of medicines and products "Synthesis".

In April, 2020 Sergey Klykov, the CEO of Pharm-center Ltd - management company of JSC Sintez, delegated a number of powers on operational management of JSC Sintez to the president (not existing earlier established post) to focus on accomplishment of strategic tasks. The post of the president was held by Rustem Muratov. Read more here.

In July, 2020 Sergey Klykov is appointed the CEO of Alium group which was created by PJSC AFK Sistema for the purpose of management of share blocks of Corporation in the pharmaceutical companies of JSC Sintez (Biokom Ltd owns) and JSC Alium (AO FP of Obolenskoye and JSC Binnopharm merges under the Alium brand assets). Read more here.